Unigene Laboratories Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2008
2009
2010
2011
2012
Cash & Short Term Investments
8,583.20
4,894.20
12,200.80
4,681.70
3,813.50
Total Accounts Receivable
4,635.00
2,221.10
1,739.40
3,462.20
76.30
Inventories
3,180.00
1,933.00
1,417.90
1,283.60
898.00
Other Current Assets
2,519.10
182.80
700.00
862.80
848.60
Total Current Assets
18,917.40
9,231.10
16,058.00
10,290.20
5,636.40
Net Property, Plant & Equipment
4,023.40
3,679.60
3,190.10
2,977.10
2,651.80
Total Investments and Advances
1,447.40
3,060.20
3,175.90
-
-
Intangible Assets
391.20
828.10
871.00
803.50
1,920.60
Other Assets
3,861.60
7,156.00
5,175.80
3,604.00
1,104.10
Total Assets
28,641.00
23,954.90
28,470.90
17,674.70
11,312.90
ST Debt & Current Portion LT Debt
-
2,360.60
-
750.00
56,398.30
Accounts Payable
708.10
1,144.40
975.00
1,472.90
731.40
Other Current Liabilities
3,295.70
6,977.10
6,325.30
3,473.80
47,328.50
Total Current Liabilities
4,003.80
10,482.10
7,300.30
5,696.80
104,458.20
Long-Term Debt
29,201.00
31,557.10
40,527.80
48,061.10
28.00
Other Liabilities
14,408.70
12,357.40
21,071.60
19,054.60
5,566.30
Total Liabilities
47,613.40
54,396.60
68,899.70
72,812.50
110,052.40
Common Equity (Total)
18,972.50
30,441.70
40,428.70
55,137.80
98,739.50
Total Shareholders' Equity
18,972.50
30,441.70
40,428.70
55,137.80
98,739.50
Total Equity
18,972.50
30,441.70
40,428.70
55,137.80
98,739.50
Liabilities & Shareholders' Equity
28,641.00
23,954.90
28,470.90
17,674.70
11,312.90
About Unigene Laboratories
View Profile
